Advaxis Inc (NASDAQ:ADXS)

1.64
Delayed Data
As of Apr 20
 -0.05 / -2.96%
Today’s Change
1.51
Today|||52-Week Range
9.55
-42.25%
Year-to-Date
No recent news for Advaxis Inc.

Today’s Trading

Previous close1.69
Today’s open1.68
Day’s range1.64 - 1.71
Volume319,077
Average volume (3 months)1,019,864
Market cap$91.4M
Data as of 4:00pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)-11.06%
Earnings growth (this year)-0.76%
Earnings growth (next 5 years)--
Revenue growth (last year)+201.16%
P/E ratioNM
Price/Sales11.45
Price/Book1.67

Competitors

 Today’s
change
Today’s
% change
IMDZImmune Design Corp-0.15-4.11%
SNDXSyndax Pharmaceutica...+0.17+1.57%
NERVMinerva Neuroscience...+0.05+0.70%
ZGNXZogenix Inc-0.10-0.24%
Data as of 4:00pm ET, 04/20/2018

Financials

Next reporting dateJune 6, 2018
EPS forecast (this quarter)-$0.59
Annual revenue (last year)$12.0M
Annual profit (last year)-$93.4M
Net profit margin-776.62%

Profile

Sector
Health Technology
Industry
Biotechnology
CEO, Chief Business Officer &
Senior VP
Anthony A. Lombardo
Chief Operating Officer &
Senior Vice President
Christopher M. Duke
Corporate headquarters
Princeton, New Jersey

Forecasts